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1. Introduction 
Sarcoidosis is an enigmatic systemic granulomatous disease of unknown etiology. It was 
first described in 1877 by Jonathon Hutchinson, an English physician (Hutchinson, 1877). 
Caesar Boeck used the term sarkoid originally in 1899 because he felt that the lesions 
resembled sarcoma (Boeck, 1899). Kuznitsky and Bittorf reported the cardinal patient with 
enlarged hilar nodes and pulmonary infiltrates on chest radiograph, describing the principle 
case of sarcoidosis (Kuznitsky & Bittorf, 1915).  
Sarcoidosis primarily affects the lung and lymphatic system. The patients are usually young 
to middle-aged adults, appearing more commonly in individuals of African descent. 
Bilateral hilar lymphadenopathy, pulmonary involvement, and ocular and cutaneous lesions 
are classic findings, however sarcoidosis can affect many other organs. Clinical and imaging 
findings are helpful in establishing the diagnosis. Histologic demonstration of noncaseating 
epithelioid cell granulomas is confirmatory for diagnosis. In 1958, Wurm and colleagues 
proposed a radiographic staging system, which still remains in widespread clinical use 
(Table 1) (Wurm et al., 1958).  
 
Stage Radiographic findings 
0 Normal 
1 Bilateral hilar adenopathy 
2 Bilateral hilar adenopathy with parenchymal opacities 
3 Parenchymal opacities 
4 Advanced lung disease with fibrosis 
Table 1. Radiographic stages of pulmonary sarcoidosis as defined by chest radiograph. 
This chapter reviews the imaging findings of sarcoidosis based on the involved organ 
systems and recommends the principle imaging study contingent upon the diagnostic 
capabilities of different modalities.  Options for radiologic evaluation of sarcoidosis 
include plain radiography, ultrasonography, scintigraphy, computed tomography (CT), 
and magnetic resonance imaging (MRI). Until the 1970s, evaluation of sarcoidosis was 
limited to plain chest radiographs. Radionuclide imaging is occasionally used to assess 
lymphatic, cardiac, and musculoskeletal involvement. With the development of CT in the 
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early 1970s, cross-sectional imaging became available. The multiplanar and 
multisequential capabilities of MRI have enhanced the characterization of sarcoid lesions 
involving different organs. 
2. Thoracic sarcoidosis 
Classically, thoracic involvement of sarcoidosis presents as bilateral hilar adenopathy which 
may occur in combination with parenchymal opacities.  The chest roentgenogram is still the 
most commonly used method for detecting lung involvement, however various other 
modalities are being used with increased frequency. Pulmonary involvement is present in 
90% of patients with sarcoidosis. 
 
  
(a)           (b) 
  
(c)          (d) 
Fig. 1. Radiographic stages of pulmonary sarcoidosis. (a) Stage 1: A 32-year-old female with 
hilar and right paratracheal lymphadenopathy. (b) Stage 2: A 61-year-old male with bilateral 
hilar adenopathy and parenchymal opacities. (c) Stage 3: A 54-year-old female with 
parenchymal opacities in the right lower lung. (d) Stage 4: A 51-year-old female with 
extensive increased interstitial markings. 
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2.1 Radiography 
Simple radiographs are sufficient for diagnosing and follow-up of sarcoidosis, although high-
resolution CT without intravenous contrast is helpful in characterizing interstitial lung disease 
and the extent of adenopathy. It is also suitable in determining the lung involvement stage, 
amount and type of reversible versus irreversible lung damage, and the overall prognosis. 
Pulmonary involvement can be categorized into five radiographic stages (Figure 1) 
(Silzbach, 1967). Pulmonary function test findings such as restrictive pattern and decreased 
carbon monoxide diffusing capacity worsen as the disease progresses from stages zero to 
four (Criado et al., 2010). 
Lymphadenopathy is the most common finding in patients with pulmonary sarcoidosis; it is 
seen in 80% of patients. Bilateral hilar lymphadenopathy is the typical pattern of 
involvement. Additionally, right paratracheal lymphadenopathy is also common. Lymph 
nodes can be of different sizes ranging from subtle enlargement to conglomerate masses.  
In 20% of patients, parenchymal infiltration can be identified on radiographs. 
Reticulonodular opacities are the most common findings and are primarily seen in the 
upper lung zones.  Large nodules are seen in patients with alveolar sarcoidosis. In cases 
with advanced disease and fibrosis, honeycombing and traction bronchiectasis may be seen. 
The upper lobes and superior segments of the lower lobes are usually involved in this 
presentation. Occasionally, cavitary lesions and pleural effusion can be demonstrated. 
2.2 Computed tomography 
High-resolution CT is more sensitive in detecting adenopathy and parenchymal involvement 
as well as differentiating reversible inflammatory features from irreversible fibrotic changes. 
The most common CT findings of pulmonary sarcoidosis are symmetric lymphadenopathy, 
micronodules with lymphagitic spread, fibrotic changes, and bilateral perihilar opacities.  
Reversible inflammatory changes consist of nodules and uncommonly, alveolar densities and 
patchy ground-glass opacities. Irreversible changes due to pulmonary fibrosis include 
honeycombing, architectural distortion, bullae formation and tractional bronchiectasis. 
 
 
Fig. 2. A 56-year-old female with hilar lymphadenopathy. 
Typically, hilar and right paratracheal lymph nodes are enlarged (Figure 2). Furthermore, as 
the disease progresses to a chronic state, nodes can become calcified (Figure 3). A symmetric 
bilateral perilymphatic micronodular distribution, commonly referred to as lymphangitic 
spread, is the most common pattern in patients with parenchymal involvement in 
pulmonary sarcoidosis (Lynch et al., 1997). Lymphangitic spread can include 
peribronchovascular, subpleural, and interlobular septal distribution of the nodules (Figure 
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4). Micronodules are defined as round nodules measuring 2-4 mm and usually seen in the 
upper and middle zones. Bilateral perihilar opacities are one of the common findings in 
thoracic sarcoidosis; these opacities are confluent nodular consolidations with irregular 
borders and central predilection (Figure 5). 
 
 
Fig. 3. A 69-year-old female with calcified hilar lymph nodes. 
 
 
Fig. 4. A 56-year-old female with pulmonary sarcoidosis. CT of the chest demonstrates 
micronodules with peribronchovascular distribution. 
 
 
Fig. 5. A 51-year-old female with sarcoidosis. CT of the chest shows bilateral perihilar densities 
(arrows). Areas of air trapping and mosaic attenuation pattern are also identified (arrowheads) 
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In 20% of patients, the initial inflammatory phase leads to fibrotic changes such as 
honeycombing, linear densities, architectural distortion and secondary traction 
bronchieactasis (Figure 6). Honeycombing refers to “destroyed and fibrotic lung tissue 
containing numerous cystic airspaces with thick fibrous walls, representing the late stage of 
various lung diseases, with complete loss of acinar architecture" (Hansell et al., 2008). Upper 
and middle zones are usually involved in a patchy distribution. Abehsera et al described 
three major patterns of pulmonary involvement in patients with fibrosis: bronchial 
distortion in 47% of patients; honeycombing in 29% of patients; and diffuse linear opacities 
in 24% of patients (Abehsera et al., 2000).  
 
       
(a)                                  (b) 
       
(c)                                (d) 
Fig. 6. Fibrotic changes in advanced sarcoidosis. (a) A 29-year-old female with sarcodidosis. 
CT of the chest demonstrates multiple cystic lesions within the left upper lobe, representing 
areas of honeycombing. (b) A 34-year-old male with sarcoidosis. CT of the chest shows areas 
of linear densities (arrow) in the left lower lobe compatible with linear scarring. (c) A 49-
year-old male with sarcoidosis. CT of the chest demonstrates architectural distortion in the 
right lung apex (arrow). (d) A 54 year-old female with sarcoidosis. CT of the chest shows 
bronchiectasis in the right upper lobe. 
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Atypical features of pulmonary involvement include unilateral lymphadenopathy, unusual 
location of lymphadenopathy, nodules and masses, patchy airspace, ground-glass, and 
linear opacities, airway involvement, fibrocystic changes, miliary opacities, and pleural 
disease. Unusual manifestations of mediastinal lymphadenopathy in a minority of patients 
may contribute to challenging diagnostic dilemmas. 
 
       
(a)           (b) 
Fig. 7. Pulmonary macronodules and masses in sarcoidosis. (a) A 34-year-old male. CT of 
the chest shows a 12 mm nodule in the left upper lobe. (b) A 39-year-old male. CT of the 
chest demonstrates a large soft tissue mass in the left upper lobe. Biopsy confirmed non-
caseating granulomatous disease in both patients. 
Nodules and masses are predominantly bilateral and multiple (Figure 7). Nevertheless, 
these lesions can occasionally present in varying manners.  “Galaxy sign” refers to multiple 
small nodules around a larger mass (Figure 8). A conglomerate of multiple micronodules is 
called a “sarcoid cluster”. Acinar or alveolar sarcoidosis refers to alveolar opacities, which 
are composed of multiple nodules causing adjacent alveoli compression and can easily be 
mistaken as pneumonia, tuberculosis, or cryptogenic organizing pneumonitis (Figure 9). 
Patchy ground-glass opacities are more commonly seen as compared to diffuse ground-
glass opacities (Figure 10). Interlobular and intralobular septal thickening may lead to a 
linear reticular pattern (Figure 11). Honeycomb-like cysts, cavitations and mycetoma 
formations are considered fibrocystic changes. 
Airway involvement is indicative of a poor prognosis (Handa et al., 2006). It can present as 
mosaic attenuation pattern, air trapping (Figure 5), tracheobronchial abnormalities, and 
atelectasis. Miliary pattern is a rare presentation of pulmonary sarcoidosis, found in less 
than one percent of cases (Figure 12). Pleural effusion, hemorrhagic or chylous pleural 
effusion, pneumothorax (Figure 12), pleural thickening, plaque-like opacities and pleural 
calcification occur in 1-4% of patients (Soskel & Sharma, 1992). 
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Fig. 8. “Galaxy sign”. A 49-year-old female. CT of the chest shows a 7 mm nodule in the left 
lower lobe (arrow) as well as multiple adjacent 2 mm nodules (arrowhead). 
 
 
 
Fig. 9. A 54-year-old female with sarcoidosis. CT of the chest shows a large alveolar density 
in the right middle lobe 
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Fig. 10. A 54-year-old female with sarcoidosis. CT of the chest shows an area of patchy 
groundglass opacity (arrow) in the right upper lobe. A confluent opacity (arrowhead) lateral 
to this area is also identified. 
 
 
 
 
Fig. 11. A 56-year-old female with sarcoidosis. CT of the chest demonstrates intralobular 
septal thickening in the right upper lobe. 
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Fig. 12. A 66-year-old male. CT of chest reveals innumerable micronodules with a miliary 
pattern. A small right-sided pneumothorax (arrow) is also noted. 
One study compared the high-resolution CT and pulmonary function test findings of 
smokers and nonsmokers with pulmonary sarcoidosis. 46 patients (23 smokers and 23 
lifelong nonsmokers) with histologically proven sarcoidosis were included. Air trapping 
and small nodules were the most common findings. The extent of emphysema was greater 
in smokers although no significant difference was seen in the extent of airway involvement 
between smokers and nonsmokers (Terasaki et al., 2005). 
2.3 Nuclear medicine 
Gallium-67 (67Ga) scintigraphy shows a relatively specific pattern of abnormal 
radiopharmaceutical uptake in thoracic lymph nodes of patients with pulmonary 
sarcoidosis referred to as “ lambda sign” . This is a distinctive pattern of increased 67Ga 
uptake in the hilar and right paratracheal lymph nodes resembling the Greek letter lambda 
(λ).  Sulivak et al evaluated 65 patients with sarcoidosis and compared 67Ga scintigraphy 
findings in these patients with 540 patients with other disorders. Lambda sign was seen in 
72% of patients with sarcoidosis and none of the patients in the comparison group (Sulavik 
et al., 1990). 
2.4 Ultrasonography 
Endobronchial ultrasound (EBUS) with transbronchial needle aspiration (TBNA) is a 
promising minimally invasive technique, which recently has been used for diagnosis of a 
wide variety of pulmonary disorders ranging from sarcoidosis to lung cancer. In one study, 
EBUS-TBNA is performed for diagnosis of sarcoidosis in 50 patients with suspected 
pulmonary sarcoidosis. Non-caseating granuloma was demonstrated in 41 of 48 patients 
(85%) with a final diagnosis of sarcoidosis (Garwood et al., 2007). 
In summary, plain radiographs are sufficient for diagnosis of pulmonary sarcoidosis and 
subsequent follow-up. High resolution CT without intravenous contrast may be helpful to 
characterize interstitial lung disease and the extent of adenopathy.  
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3. Cardiac sarcoidosis 
Although clinical cardiac involvement in sarcoidosis is uncommon, it is still a major 
contributing factor in disease prognosis (Perry & Vuitch, 1995). Acute cardiac failure, 
ventricular arrhythmias, heart blockage, and sudden cardiac death are several complications 
of sarcoidosis in the cardiovascular system. Myocardial involvement is more common than 
pericardial disease.  The basal and lateral walls of the left ventricle as well as the septum are 
typically involved, while the endocardium is usually spared. As with any other organ, 
cardiac sarcoidosis can be divided into three stages including initial edema, granulomatous 
infiltration and scarring. 
3.1 Nuclear medicine 
Resting Thallium-201 and Tc-99m-methoxyisobutylisonitrile (Tc-99m-MIBI) scintigraphy 
demonstrate segmental regions of decreased radiopharmaceutical uptake in the 
myocardium although these foci do not correspond to histologic findings for an unknown 
reason. Reverse distribution has been described in patients with cardiac sarcoidosis as 
indicated by increased uptake in Thallium-201 on stress images.  
67Ga scintigraphy is useful for diagnosis of the active inflammatory phases of cardiac 
sarcoidosis including the initial edema and granulomatous infiltration phases. Presence of 
areas of increased uptake in 67Ga scintigraphy correlates with a favorable response to 
corticosteroid treatment. 
18F-fluorodeoxyglucose (FDG) accumulates in inflammatory cells and although it is 
nonspecific, FDG-Positron Emission Tomography (PET) may be a useful modality for 
detecting inflammatory processes such as sarcoidosis. Okumura et al (Okumura et al., 2004) 
described that fasting FDG-PET can detect cardiac sarcoidosis in earlier stages in 
comparison to other radiopharmaceuticals. 
 
 
    
 
Fig. 13. Short-axis gadolinium-enhanced T1-weighted image shows an area of diffuse 
enhancement (arrows) in the lateral wall of the left ventricle representing edema in the early 
stage of cardiac sarcoidosis. (Courtesy of Prof. Olivier Vignaux, University René Descartes, 
Paris, France) 
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Fig. 14. Four-chamber delayed gadolinium-enhanced T1-weighted image demonstrates an 
area of nodular enhancement (arrow) in the septum compatible with granulomatous 
infiltration. Diffuse lateral wall enhancement (arrowhead) is also noted. (Courtesy of Prof. 
Olivier Vignaux, University René Descartes, Paris, France) 
 
 
Fig. 15. Axial CT image of the chest in a patient with sarcoidosis shows an area of diffuse 
enhancement in the lateral wall of the left ventricle, representing presumed cardiac 
involvement. (Courtesy of Dr. Takashi Koyama, Kyoto University of Medicine, Kyoto, Japan) 
3.2 Magnetic resonance imaging 
Magnetic resonance imaging is a sensitive method for diagnosis of cardiac sarcoidosis. 
Initial edema will present as regions of increased signal intensity on T2-weighted sequences 
and early contrast enhancement within the myocardium (Figure 13). Granulomatous 
infiltration can be visualized as nodular areas of signal intensity on T2-weighted images 
with delayed contrast enhancement (Figure 14). Eventually focal areas of wall thinning and 
hypokinesis may appear representing a progression into the third phase, scarring. These 
lesions correspond to foci of delayed enhancement in the subepicardial layer. Segmental 
contraction abnormalities can be seen, however severe disease can lead to diffuse 
contraction abnormalities and wall thickening. 
Ichinose et al performed delayed contrast-enhanced cardiac MRI in 40 patients with 
sarcoidosis, 11 having cardiac involvement (Ichinose et al., 2008). Myocardial enhancement 
was present in 91% of patients with cardiac sarcoidosis (10 of the 11), whereas none of the 29 
patients without cardiac sarcoidosis showed enhancement. They concluded that myocardial 
lesions can be predominantly localized in the basal and subepicardial myocardium. 
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Clinically, cardiac sarcoidosis is found in five percent of patients, however it is present in 
approximately 20-30% of autopsy studies indicating that often it can be asymptomatic.  In 
those patients that display clinical symptoms, cardiac sarcoidosis can be life-threatening and 
detection by MRI becomes increasingly important.  MRI with gadolinium is the forefront 
modality in following cardiac sarcoidosis (Vignaux, 2005). CT is not a commonly used 
modality for evaluation of cardiac sarcoidosis. Nevertheless, in a few case reports, CT 
reveals a similar pattern of myocardial enhancement as in MRI (Figure 15). 
4. Abdominal sarcoidosis 
Abdominal visceral involvement is frequently reported in autopsy series of patients with 
sarcoidosis (Iwai et al., 1988). Nonetheless, most of these patients are asymptomatic and 
organ dysfunction is uncommon. Abdominal lymphadenopathy as well as genitourinary, 
pancreatic, and gastrointestinal sarcoidosis have been documented with the liver and spleen 
being the most frequently affected abdominal organs.  
4.1 Liver and spleen 
Hepatomegaly is the most common imaging finding of hepatic sarcoidosis. Liver 
dysfunction is occasionally seen; however end stage liver disease manifesting as cirrhosis or 
portal hypertension is rarely reported. On ultrasonography, hepatic sarcoidosis could 
represent as diffuse or patchy areas of increased echogenicity although the enlarged liver 
might remain homogenous. Another frequently seen pattern of involvement presents as 
multiple low-density lesions throughout the liver. These lesions can range from 1-2 
millimeters to several centimeters. Sarcoidosis nodules could present as hypoechoic or 
hyperechoic lesions on sonographic examination. These nodules remain unenhanced on 
contrast-enhanced CT (Figure 16) and present as low signal intensity nodules with no 
evidence of enhancement on MRI. Rarely, cirrhosis can be seen with involvement of 
intrahepatic biliary ducts. When involvement includes the extrahepatic ducts, 
granulomatous infiltration can lead to obstructive jaundice. 
Splenomegaly is a common finding of sarcoidosis, reported in up to 33% of patients 
(Warshauer & Lee, 2004). Hypodense nodular disease is frequently seen while calcified 
lesions have also been reported (Figure 17). Nodular splenic disease has similar imaging 
characteristic as hepatic nodular disease (Figure 18).  
 
 
Fig. 16. A 41-year-old female with upper abdominal pain. Axial contrast-enhanced CT image 
of the abdomen at the level of the T11 vertebra reveals low attenuating geographic lesions 
(arrows) in the liver and spleen. Splenomegaly is also present. Biopsy confirmed non-
caseating granulomas. 
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Fig. 17. A 47-year-old female with systemic sarcoidosis. Ultrasonography image of the 
spleen shows a hyperechoic lesion withon the parenchyma compatible with a calcified 
splenic granuloma. 
 
 
 
Fig. 18. A 30-year-old male with systemic sarcoidosis. Axial contrast-enhanced CT image 
shows multiple small low attenuating nodules throughout the spleen. 
4.2 Lymph nodes 
Lymphadenopathy is another common finding of abdominal sarcoidosis. Constitutional 
symptoms such as fever, fatigue and weight loss have been reported. In comparison with 
lymphoma, one study showed smaller nodes and less conglomerate mass formation in 
abdominal lymphadenopathy of sarcoidosis (Britt et al., 1991).  Enlarged lymph nodes can 
compress on adjacent organs causing obstruction of hollow organs such as the biliary ducts 
or ureters leading to obstructive jaundice or hydronephrosis. These nodes appear 
hypoechoic on ultrasonography (Figure 19a), of soft tissue density on CT (Figure 19b), and 
mildly enhancing with increased T2 signal intensity on MRI.  
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(a)          (b) 
Fig. 19. Abdominal lymphadenopathy. (a) A 34-year-old male with jaundice and systemic 
sarcoidosis. An ultrasonography image of the midline upper abdomen shows an enlarged 
lymph node (arrow) near the porta hepatis. (b) Axial contrast-enhanced CT image of the 
upper abdomen confirms intrabdominal lymphadenopathy (arrow). 
4.3 Pancreas 
Pancreatitis due to granulomatous infiltration of the pancreatic duct secondary to 
sarcoidosis is an uncommon manifestation of sarcoidosis. Additionally, focal pancreatic 
masses have been reported. These masses appear hypoechoic on ultrasonography and 
hypodense on CT. These lesions typically do not enhance or enhance minimally on CT. 
4.4 Gastrointestinal tract 
Sarcoidosis can involve any part of the gastrointestinal tract. In the stomach focal nodular 
involvement with wall thickening is a classic finding. Gastric wall ulceration is another 
manifestation of sarcoidosis. Duodenal, colonic and appendiceal involvement have also 
been reported. Focal wall thickening is the most common imaging presentation. 
4.5 Genitourinary tract 
Hypercalcemia and hypercalciuria in the setting of sarcoidosis can lead to nephrocalcinosis, 
nephrolithiasis, and interstitial calcium deposition, which can be visualized on CT and 
ultrasonography. On CT, multiple isodense lesions with relative hypo-enhancement 
compared to normal renal parenchyma has been reported. Testicular involvement is rare, 
appearing as hypodense lesions on CT and hypoechoic areas on ultrasonography (Figure 
20). 
Organomegaly and nodular disease are the common manifestations of abdominal 
sarcoidosis. However, these findings are generally nonspecific and could be present in other 
settings such as neoplasms and infectious diseases. A combination of imaging findings and 
clinical signs and symptoms will help with further delineation of the disease process and 
possible need for tissue biopsy. 
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(a)                    (b) 
Fig. 20. A 30-year-old male with sarcoidosis. (a) Axial contrast-enhanced CT image 
incidentally shows hypodense lesions within the testes. (b) Subsequent sagittal 
ultrasonography image of the testes show multiple small round hypoechoic lesions 
(arrow). 
5. Neurosarcoidosis 
Symptomatic involvement of the nervous system is reported in 5% of patients with 
sarcoidosis.  However, asymptomatic neurosarcoidosis has been reported in up to 25% of 
cases in postmortem studies (Johns & Michele, 1999).  Isolated neurosarcoidosis is rarely 
seen.  Although sarcoidosis can involve the entire nervous system and its supportive tissues, 
Central Nervous System (CNS) involvement is far more common.  Clinical symptoms of 
neurosarcoidosis are nonspecific; the involved region of the CNS determines the presenting 
symptoms.  Vision loss, facial nerve involvement, headache, neck stiffness and seizure have 
all been described as correlated symptoms.  Imaging characteristics of neurosarcoidosis are 
nonspecific so a lesion biopsy is occasionally performed to reach a definite diagnosis.  
5.1 Leptomeningeal involvement 
Enhancing thickened leptomeninges on contrast-enhanced T1-weighted sequences are the 
most common imaging finding of CNS involvement with sarcoidosis; it has been reported in 
40% of patients with neural involvement (Nowak & Widenka, 2001).  Nodular and diffuse 
patterns have been described with the basilar meninges being most commonly involved 
(Figure 21).  Some authors have hypothesized that parenchymal involvement is an extension 
of leptomeningeal disease via the perivascular spaces (Junger et al., 1993).  In the spinal cord 
linear and nodular enhancing extramedullary lesions are also common.  Hydrocephalus 
secondary to adhesions or abnormal CSF resorption can be seen in patients with 
leptomeningeal sarcoidosis. 
5.2 Parenchymal disease 
Multiple high signal intensity lesions on T2-weighted sequences are the most common 
finding in patients with parenchymal involvement.  In the brain, these lesions are mainly 
located in the periventricular white matter.  Although non-enhancing lesions are typical, 
contrast enhancement can also be seen (Figure 22). Occasionally, low signal intensity masses 
on T2-weighted sequences have been reported. 
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(a)                                                                         (b) 
Fig. 21. Leptomeningeal sarcoidosis. (a) A gadolinium-enhanced axial T1-weighted image in 
a 27-year-old male and (b) a gadolinium-enhanced sagittal T1-weighted image in a 38-year-
old male with systemic sarcoidosis show curvilinear areas of abnormal enhancement along 
the sulci and basal cisterns, representing leptomeningeal sarcoidosis. 
In the spinal cord, intramedullary sarcoidosis presents as fusiform high T2-signal intensity 
segmental lesions with decreased signal intensity on T1-weighted sequences.  Patchy 
enhancement on contrast-enhanced T1-weighted sequences is common (Figure 23). One 
study evaluated clinical, laboratory, and MRI profiles in 31 patients with spinal cord 
sarcoidosis (Cohen-Aubart et al., 2010). Spinal cord MRIs performed in 26 patients with 
spinal cord involvement revealed intramedullary T2-hyperintensities that were extensive 
and heterogeneous with a central distribution in axial slides. They concluded that a spinal 
cord MRI study may be a useful tool in the diagnosis of spinal cord sarcoidosis. 
Cranial nerve involvement is another feature of parenchymal sarcoidosis with contrast 
enhancing nerve enlargement being typical.  Optic nerve involvement is frequently seen and 
can be bilateral or unilateral (Figure 24). In MRI scans of 15 patients with orbital or optic 
pathway involvement, eight patients had MR evidence of optic nerve involvement by 
sarcoid granuloma (Carmody et al., 1994). Optic chiasmal involvement, periventricular 
white matter abnormalities, perineural enhancement, and optic nerve enlargement were 
commonly identified. Less frequently, optic nerve atrophy, increased T2 signal intensity in 
the optic radiations, and orbital masses with MR signal characteristics similar to a 
pseudotumor were reported.   
Additionally, other orbital structures such as orbital fat, muscles, globe and lacrimal glands 
can be involved (Figure 25).  Mass-like lacrimal and muscle infiltration, pseudotumor-like 
intraorbital masses and rarely uveal and scleral nodularity have been reported.  Facial nerve 
paralysis can be seen with facial nerve (VII) involvement. Nevertheless, there is no 
correlation between imaging findings and clinical presentation. 
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(a)             (b) 
 
(c)             (d) 
Fig. 22. A 40-year-old male with memory loss, confusion, disorientation and 
multisystemic sarcoidosis. (a) Axial T1-weighted MR image at the level of the basal 
ganglia is unremarkable. (b) Axial T2 and (c) axial FLAIR images show areas of increased 
signal intensity within the white matter of the medial frontal lobes, left being greater than 
right. (d) Axial gadolinium-enhanced image shows minimal enhancement in the medial 
frontal lobes. 
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(a) 
    
(b)                                                       (c) 
 
Fig. 23. Intramedullary sarcoidosis. (a) A 27-year-old male with sarcoidosis. Axial T2-
weighted image at the level of the conus medullaris shows an area of increased signal 
intensity within the conus (arrow) representing intramedullary involvement. (b) A 27-
year-old male with systemic sarcoidosis presented with paraplegia. A T2-weighted 
sagittal image shows patchy increased signal intensity within the spinal cord at the C7-T2 
level as well as T6-T7 level (arrows) and (c) a sagittal gadolinium-enhanced T1-weighted 
image shows abnormal enhancement of these lesions (arrows), representing 
intramedullary involvement. 
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(a)                                                                                (b) 
Fig. 24. A 39-year-old male with vision loss and systemic sarcoidosis. (a) T1-weighted image 
shows thickened pituitary infundibulum (arrow). (b) Gadolinium-enhanced T1-weighted 
image shows enhancement of the optic nerves (arrowheads) and pituitary infundibulum 
(arrow). 
 
 
   (a)                                                                              (b) 
   
               (c)                                                    (d)                                  (e) 
Fig. 25. A 44-year-old male with pulmonary sarcoidosis, left eye pain and sixth nerve palsy. 
(a) Axial T1-weighted image shows a low signal intensity lesion in the left orbital apex 
(arrow). (b) Gadolinium-enhanced fat suppressed T1-weighted image shows enhancement 
of the previously seen lesion (arrow). Slight enlargement of the left lacrimal gland is noted 
(arrowhead). (c) Coronal fat suppressed T2-weighted image shows diffuse increased signal 
intensity with in the left intraconal fat, representing an inflammatory process (arrow). (d) 
and (e) 67Gallium SPECT images show increased radiopharmaceutical activity in the 
lacrimal and parotid glands respectively. 
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5.3 Dural Involvement 
Diffuse thickening of the dura and focal nodular dural masses are common manifestations 
of dural sarcoidosis.  Dural involvement with sarcoidosis is much more commonly found in 
the brain rather than in the spine. In the brain, these lesions appear dark on T2-weighted 
sequences and enhance diffusely on contrast-enhanced T1-weighted sequences (Figure 26).  
Unlike in leptomeningeal disease, involvement of the basal cisterns and perivascular spaces 
are not seen.  When seen in the spine, dural-based high signal intensity masses on T2-
weighted sequences are characteristic (Figure 27). 
 
 
(a)                                                                  (b) 
 
(c)         (d) 
Fig. 26. A 66-year-old male with worsening headaches and sarcoidosis. (a) A T2-weighted 
image shows diffuse low signal intensity in the dura. (b), (c), and (d) Axial, sagittal and 
coronal gadolinium-enhanced images demonstrate diffuse and nodular enhancement of the 
dura respectively (arrows). 
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(a) 
 
(b) 
 
(c) 
Fig. 27. A 27-year-old male with confusion and thoracic sarcoidosis. (a) T2-weighted image 
shows irregular areas of increased signal intensity (arrow) at the surface of the cauda 
equina. (b) Axial and (c) sagittal gadolinium enhanced T1-weighted images show nodular 
enhancement (arrows) compatible with dural involvement. 
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Refractory and recurrent CNS sarcoidosis is common (Christoforidis et al., 1999).  Imaging 
characteristics of neurosarcoidosis are nonspecific and correlation between a response to 
treatment and resolution of imaging findings is not well established.  Nonetheless, imaging 
can be useful for follow-up in patients with known CNS sarcoidosis. Lexa et al evaluated the 
role of MRI in the diagnosis and treatment of 24 patients with neurosarcoidosis. White 
matter and periventricular high signal intensity on T2-weighted sequences, leptomeningeal 
enhancement, parenchymal mass, lacrimal gland mass, hydrocephalus, ventriculomegaly, 
periventricular enhancement, extraaxial mass, optic chiasmal enhancement, nerve root 
enhancement, enlarged pituitary infundibulum, and pontine infarct were identified. They 
concluded that enhancement was a useful clue to the diagnosis in 15 of 17 cases in which 
gadolinium was used (88%). Additionally, it was shown that MRI is useful in the evaluation 
of treatment response in patients with neurosarcoidosis particularly in the leptomeningeal 
and parenchymal lesions (Lexa & Grossman, 1994). 
Symptomatic neurosarcoidosis may be present in 3%-5% of patients with sarcoidosis. 
Although imaging findings are nonspecific, recognition of common patterns may be helpful 
in the planning for further diagnostic tests and disease surveillance. MRI with gadolinium is 
the study of choice for initial diagnosis as well as follow-up evaluation of neurosarcoidosis.  
6. Musculoskeletal sarcoidosis 
Although sarcoidosis can involve any organ, symptomatic musculoskeletal involvement is 
uncommon. More specifically, muscular, articular and osseous sarcoidosis can be seen. 
Imaging findings are nonspecific in most cases. 
6.1 Muscular involvement 
Symptomatic myopathy is an extremely rare manifestation of sarcoidosis, which is seen in 
less than 0.5% of patients (Douglas et al., 1973). However, asymptomatic granulomatous 
disease is seen commonly in up to 80% of patients (Baydur et al., 1993). Chronic myopathy, 
palpable lesions and acute myositis are different presentations of symptomatic muscular 
involvement with sarcoidosis. Typically, sarcoid myopathy has a symmetrical pattern with 
bilateral involvement of the proximal muscles of the extremities. Nevertheless, any 
muscular structure including the respiratory muscles can be involved.  
Oval nodules with a central area of low signal intensity surrounded by an area of increased 
signal intensity in T2-weighted images are characteristic for nodular sarcoidosis.  Evaluation 
of sonographic and MRI findings in three cases of the nodular type of muscular sarcoidosis 
revealed intramuscular hypoechoic well-defined nodules in all three patients (Tohme-Noun 
et al., 2004). On MRI, the nodules were iso- or hyperintense on T1-weighted sequences. On 
T2-weighted images and STIR sequences, intramuscular nodules of homogeneous high 
signal intensity were observed. Homogeneous enhancement in all nodules on gadolinium-
enhanced T1-weighted sequences was characteristic.  
In chronic myopathy, MRI and CT occasionally show muscle atrophy. With acute myositis, 
on MR imaging diffuse increased T2 signal intensity of involved muscles may be noted. CT 
may show thickening of the involved musculature (Figure 28). 67Ga scintigraphy reveals 
nonspecific diffuse increased radiopharmaceutical uptake in the involved musculature in 
both acute myositis and chronic myopathy. 
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Fig. 28. A 44-year-old male with left eye pain and sarcoidosis. Axial CT image shows mild 
thickening of the left lateral rectus muscle (arrow) compatible with granulomatous 
infiltration. 
6.2 Joint involvement 
Arthralgia with polyarticular involvement of the distal joints of the extremities is a common 
early finding of sarcoidosis. Additionally, MRI findings such as synovitis, bursitis, 
tenosynovitis, and tendonitis have been reported in patients with sarcoidosis (Figure 29). 
Tissue biopsy might be necessary for definite diagnosis as these findings are nonspecific.  
 
 
Fig. 29. Posteroanterior radiograph of the right hand shows sausage-like dactylitis of the 
second to fifth digits in a patient with sarcoidosis, representing synovitis. Multiple classic 
osteolytic bony lesions (arrows) as well as sclerotic foci at the base of the middle phalanges 
of the forth and fifth digits (arrowheads) are also noted. (Courtesy of Drs. Shipley, 
Weinstein and Wissman. University of Cincinnati, Ohio, USA) 
6.3 Osseous involvement 
Osseous sarcoidosis has been reported in about 5% of patients (Johns & Michele, 1999). Plain 
radiographs are the first imaging modality for diagnosis of osseous sarcoidosis. Osteolysis 
with a lacy trabecular pattern is the characteristic findings on radiographs (Figure 30). 
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Typically, small bones of the hand and foot are involved although the vertebral body 
(Figure 31), skull, and long bones may also be affected rarely. Cyst formation with a 
“punched out”  pattern appearing as well-circumscribed lytic lesions with nonsclerotic 
margins is also common. Pathologic fractures secondary to extensive bony erosion have 
been reported (Figure 32). Periosteal reaction is usually not present.  Furthermore, osseous 
sarcoidosis can also present as osteosclerosis, as evidenced by nodular opacities in the 
medullary cavity on plain radiographs (Figure 29). 
99mTc-pyrophosphate scintigraphy is more sensitive in detecting osseous sarcoidosis in 
comparison to plain radiographs. Areas of increased radiopharmaceutical activity correspond 
to active granulomatous infiltration. Nuclear imaging findings are nonspecific for sarcoidosis; 
however 99mTc bone scintigraphy can be used effectively for monitoring disease activity. 
MRI is the most sensitive imaging modality for detecting osseous sarcoidosis. Typically, 
sarcoid bony lesions appear hypointense on T1-weighted sequences and hyperintense on 
T2-weighted, inversion-recovery, and fat-saturated proton-density–weighted MR sequences. 
Occasionally, the lesions can have low signal intensity.  
Occult lesions, soft tissue involvement and cortical disruption may also be identified with 
MR imaging in osseous sarcoidosis. In the long bones, sarcoidosis can be seen as well-
defined discrete masses, infiltrative marrow lesions and ill-defined mass-like lesions, which 
may enhance after administration of contrast. These lesions can be replaced with fat or 
fibrotic tissues, indicating the chronicity of the disease. 
In vertebral bodies lytic lesions with sclerotic margins are typical which may extend into the 
pedicles. Sclerotic or mixed lytic and sclerotic involvement as well as disc involvement is all 
relatively rare. In the skull, sarcoid lesions are usually well-defined expansile lytic areas 
with a “punched out”  pattern, which can be visualized on CT. Skull lesions are seldom seen 
alone and are customarily associated with other bony lesions when osseous involvement of 
sarcoidosis is present (Yaghmai, 1983). 
 
 
Fig. 30. Coned-down posteroanterior radiograph of the right hand in a patient with 
sarcoidosis shows osteolytic lesions with a lacy pattern within the middle phalanx of the 
second digit. (Courtesy of Drs. Shipley, Weinstein and Wissman, University of Cincinnati, 
Cincinnati, Ohio, USA) 
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Fig. 31. A 50-year-old male with sarcoiodosis. PET/ CT images show a lytic lesion with 
increased FDG activity within the posterior aspect of the L3 vertebral body. (Rajebi et al. 
Uncommon osseous involvement in multisystemic sarcoidosis.  Ann Saudi Med. 2009;29:485-6) 
 
 
Fig. 32. Coned-down posteroanterior radiograph of the feet in a patient with sarcoidosis 
shows a large osteolytic lesion in the distal phalanx of the right first digit causing a 
pathological fracture. (Courtesy of Dr. Hojnowski, SUNY Upstate Medical University, 
Syracuse, New York, USA) 
Compared to conventional radiography and nuclear scintigraphy, MRI with gadolinium is 
more sensitive in detection of lesions in patients with musculoskeletal sarcoidosis. 
Nonetheless, in most cases these findings are nonspecific and correlation with clinical and 
laboratory findings is essential. 
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7. FDG-PET and PET/CT 
FDG-PET and PET/ CT identify areas of abnormally increased glucose transport and 
metabolism. This capability makes FDG-PET imaging a suitable modality in conditions with 
increased glucose metabolism such as cancer and inflammatory disease. However, pattern 
and intensity of FDG uptake are nonspecific in multisystemic disorders such as sarcoidosis 
and can be mistaken with lymphoma and diffuse metastatic diseases (Figure 31 and 33) 
(Rajebi et al., 2009). Despite this, FDG uptake value can decrease after treatment of 
sarcoidosis and FDG-PET and PET/ CT can be useful for monitoring the disease and efficacy 
of the treatment (Brundin et al., 1994).  
 
 
Fig. 33. A 37-year-old female with mediastinal lymphadenopathy on chest radiograph (not 
shown). An FDG-PET/ CT shows extensive FDG-avid hilar, mediastinal, intrabdominal and 
inguinal lymphadenopathy. Biopsy confirmed the diagnosis of sarcoidosis. (Courtesy of Dr. 
McGrath, SUNY Upstate Medical University, Syracuse, New York, USA) 
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It has been shown that persistent retention of FDG correlates with refractory disease. Umeda 
et al evaluated the prognostic value of dual time point FDG-PET in patients with pulmonary 
sarcoidosis.  In this study, twenty-one patients with pulmonary sarcoidosis underwent an 
early FDG-PET at 60 minutes and a delayed FDG-PET scan at 180 minutes after the injection 
of FDG. Standardized uptake values (SUVs) at the two time points and the retention index 
(RI-SUV) calculated from these were assessed. To evaluate disease progression, all patients 
underwent chest CT one year after the initial FDG-PET. RI-SUV was significantly higher in 
patients with increased or unchanged pulmonary lesions at follow-up CT than in patients 
with improved pulmonary lesions indicating that RI-SUV can be a good indicator of disease 
progression (Umeda et al 2011).  
With FDG-PET/ CT, it is postulated that the addition of typical CT findings in patients with 
multisystemic disease such as hilar and paratracheal lymphadenopathy and parenchymal 
involvement in pulmonary sarcoidosis, can increase usefulness of this modality in 
evaluation of treatment response in sarcoidosis. 
8. Conclusion 
Sarcoidosis is a multisystemic disease, which can involve any organ in the body. Similar 
to presenting signs and symptoms, imaging findings of sarcoidosis are diverse. 
Conventional radiography is useful in initial evaluation of pulmonary and 
musculoskeletal sarcoidosis. Ultrasonography is playing an emerging role in the diagnosis 
of pulmonary involvement. The modality of choice for evaluation of the parenchymal 
lung disease is CT. MRI findings in cardiac sarcoidosis are relatively specific and 
advantageous in diagnosis. Furthermore, MRI is an extremely invaluable tool for initial 
diagnosis and treatment response in neurosarcoidosis. Extent of musculoskeletal 
sarcoidosis is also best evaluated with MRI. Although the imaging findings in abdominal 
sarcoidosis are nonspecific, CT and ultrasonography are helpful in evaluation of organ 
involvement and lymphadenopathy. FDG-PET/ CT may be useful in evaluating disease 
progress and treatment efficacy. 
Clinicians and radiologists should be familiar with typical as well as atypical imaging 
findings of sarcoidosis. This may decrease the unnecessary workup and prevent needless 
patient discomfort.  
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